In February 2013, a federal court dismissed a class-action lawsuit filed against Bayer for allegedly deceiving consumers with false advertising for Citrical CS, a calcium supplement, that claimed that a single dose of the supplement was equivalent to competing supplements, which require two doses. The basis of the complaint was a report published by the National Advertising Division of the BBB stating that the sole study Bayer had offered to support its labeling claims was unreliable.  The court dismissing the case decided that plaintiffs’ allegations weren’t strong enough to make out a legal claim. (John Gaul v. Bayer Healthcare LLC, Case No. 2:12-cv-05110, D. NJ).


The Latest


Show More